Basak S, Iktidar M, Chowdhury R, Khatun A, Rahman A, Miah S
Ann Med Surg (Lond). 2024; 86(3):1346-1351.
PMID: 38463129
PMC: 10923282.
DOI: 10.1097/MS9.0000000000001780.
Ho G, Wun T, Muffly L, Li Q, Brunson A, Rosenberg A
Cancer. 2018; 124(9):1938-1945.
PMID: 29451695
PMC: 6911353.
DOI: 10.1002/cncr.31296.
Ho G, Jonas B, Li Q, Brunson A, Wun T, Keegan T
Br J Haematol. 2017; 177(5):791-799.
PMID: 28419422
PMC: 5444943.
DOI: 10.1111/bjh.14631.
Tay J, Allan D, Beattie S, Bredeson C, Fergusson D, Maze D
BMJ Open. 2016; 6(10):e013483.
PMID: 27798034
PMC: 5093651.
DOI: 10.1136/bmjopen-2016-013483.
Desborough M, Hadjinicolaou A, Chaimani A, Trivella M, Vyas P, Doree C
Cochrane Database Syst Rev. 2016; 10:CD012055.
PMID: 27797129
PMC: 5321521.
DOI: 10.1002/14651858.CD012055.pub2.
Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.
Desborough M, Estcourt L, Doree C, Trivella M, Hopewell S, Stanworth S
Cochrane Database Syst Rev. 2016; (8):CD010982.
PMID: 27548292
PMC: 5019360.
DOI: 10.1002/14651858.CD010982.pub2.
Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party.
Tagariello G, Castaman G, Falanga A, Santoro R, Napolitano M, Storti S
Blood Transfus. 2016; 14(6):521-526.
PMID: 27416570
PMC: 5111376.
DOI: 10.2450/2016.0321-15.
Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012.
Park E, Lee H, Won Y, Ju H, Oh C, Ingabire C
Blood Res. 2016; 50(4):204-17.
PMID: 26770948
PMC: 4705046.
DOI: 10.5045/br.2015.50.4.204.
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
Estcourt L, Stanworth S, Doree C, Hopewell S, Trivella M, Murphy M
Cochrane Database Syst Rev. 2015; (11):CD010983.
PMID: 26576687
PMC: 4717525.
DOI: 10.1002/14651858.CD010983.pub2.
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
Estcourt L, Stanworth S, Doree C, Trivella M, Hopewell S, Blanco P
Cochrane Database Syst Rev. 2015; (10):CD010984.
PMID: 26505729
PMC: 4724938.
DOI: 10.1002/14651858.CD010984.pub2.
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
Crighton G, Estcourt L, Wood E, Trivella M, Doree C, Stanworth S
Cochrane Database Syst Rev. 2015; (9):CD010981.
PMID: 26422767
PMC: 4610062.
DOI: 10.1002/14651858.CD010981.pub2.
Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysis.
Percival M, Tao L, Medeiros B, Clarke C
Cancer. 2015; 121(12):2004-12.
PMID: 25739348
PMC: 4465209.
DOI: 10.1002/cncr.29319.
Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt L, Stanworth S, Doree C, Trivella M, Hopewell S, Murphy M
Cochrane Database Syst Rev. 2015; (3).
PMID: 25722652
PMC: 4338578.
DOI: 10.1002/14651858.CD010984.
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt L, Stanworth S, Doree C, Trivella M, Hopewell S, Murphy M
Cochrane Database Syst Rev. 2015; (3).
PMID: 25722651
PMC: 4338576.
DOI: 10.1002/14651858.CD010983.
Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt L, Gregg R, Stanworth S, Doree C, Trivella M, Murphy M
Cochrane Database Syst Rev. 2015; (3).
PMID: 25722650
PMC: 4338548.
DOI: 10.1002/14651858.CD010982.
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt L, Crighton G, Wood E, Stanworth S, Trivella M, Doree C
Cochrane Database Syst Rev. 2015; (3).
PMID: 25722649
PMC: 4338539.
DOI: 10.1002/14651858.CD010981.
Intracranial haemorrhage in thrombocytopenic haematology patients--a nested case-control study: the InCiTe study protocol.
Estcourt L, Stanworth S, Collett D, Murphy M
BMJ Open. 2014; 4(2):e004199.
PMID: 24508852
PMC: 3919001.
DOI: 10.1136/bmjopen-2013-004199.
Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia.
Josephson C, Granger S, Assmann S, Castillejo M, Strauss R, Slichter S
Blood. 2012; 120(4):748-60.
PMID: 22538854
PMC: 3462047.
DOI: 10.1182/blood-2011-11-389569.
[Thrombocyte transfusion: clinical aspects, follow-up and complications].
Sohngen D, Schneider W
Klin Wochenschr. 1991; 69(9):379-86.
PMID: 1921239
PMC: 7095859.
DOI: 10.1007/BF01647409.
Platelet transfusions.
Kelton J, Blajchman M
Can Med Assoc J. 1979; 121(10):1353-8.
PMID: 391376
PMC: 1704511.
